Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Uncategorized

    Uncategorized

    China approves 17 anti-cancer drugs for medical insurance coverage

    China approves 17 anti-cancer drugs for medical insurance coverage

    Medical Dialogues Bureau10 Oct 2018 10:19 AM IST
    SHANGHAI: China has approved 17 anti-cancer drugs for inclusion in its national health insurance system, the government said, part of its efforts to...
    NPPA fixes maximum retail prices of 92 drugs, details

    NPPA fixes maximum retail prices of 92 drugs, details

    Ruby Khatun Khatun16 Aug 2018 5:52 PM IST
    New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
    Merck KGaAs lung cancer drugs show promise in early-stage trials

    Merck KGaA's lung cancer drugs show promise in early-stage trials

    Ruby Khatun Khatun17 May 2018 9:45 AM IST
    FRANKFURT: Germany’s Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients, potentially...
    Lupins JV completes global trials for rheumatoid arthritis biosimilar

    Lupin's JV completes global trials for rheumatoid arthritis biosimilar

    Ruby Khatun Khatun8 Feb 2018 11:00 AM IST
    PUNE: Drug major Lupin said its joint venture with Japanese firm Yoshindo, YL Biologics, has completed global phase III trials of its Etanercept...
    Narayana Hrudayalaya plans Rs 500 crore expansion,to enter Africa

    Narayana Hrudayalaya plans Rs 500 crore expansion,to enter Africa

    Ruby Khatun Khatun20 Nov 2017 10:18 AM IST
    Mumbai: Leading private sector hospital chain Narayana Hrudayalaya has chalked out a Rs 500 crore expansion plan, which will see it entering...
    Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

    Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

    supriya kashyap kashyap15 April 2017 9:40 AM IST
    Royal Philips, a global leader in health technology, announced it has received regulatory clearance (via De Novo classification) from the U.S. Food...
    Investments set India as hot healthcare destination: PWC Report

    Investments set India as hot healthcare destination: PWC Report

    supriya kashyap kashyap26 March 2017 11:08 AM IST
    Mumbai : Private equity and venture capital funding in healthcare over the past five years along with a slew of investments from global players has...
    Mylan Launches Generic Aromasin® Tablets

    Mylan Launches Generic Aromasin® Tablets

    supriya kashyap kashyap17 March 2017 11:52 AM IST
    England : Mylan N.V. announced the U.S. launch of Exemestane Tablets, 25 mg, a generic version of the reference listed drug, Pfizer's Aromasin®...
    Dr Reddy

    Dr Reddy's Lab acquires Kolkata-based NBFC

    supriya kashyap kashyap6 March 2017 11:47 AM IST
    New Delhi : Dr Reddy's Laboratories announced that it has acquired 100 per cent stake in Imperial Credit Private Ltd, a Kolkata-based non-banking...
    Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion

    Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion

    supriya kashyap kashyap14 Feb 2017 12:38 PM IST
    Botox maker Allergan Plc agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people slim down by...
    Daiichi Sankyo closes RnD Division in India

    Daiichi Sankyo closes RnD Division in India

    savita thakur thakur12 Jan 2017 1:11 PM IST
    MUMBAI: Daiichi Sankyo India Pharma Pvt. Ltd. (DSIN), an organization working in the field of innovative pharmaceutical Research & Development...
    USFDA Accepts BLA for Mylan and Biocon

    USFDA Accepts BLA for Mylan and Biocon's Proposed Biosimilar Trastuzumab

    supriya12 Jan 2017 11:22 AM IST
    Bengaluru : Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration has accepted Mylan's biologics license application (BLA)...
    Next

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Government of India bans Ofloxacin, Ornidazole injection combination

    Government of India bans Ofloxacin, Ornidazole injection combination

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    Why Family Health Insurance Plan needs a Timely Re-Evaluation?

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok